LYRA
Lyra Therapeutics, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Lyra Therapeutics (LYRA) Stock: Buy, Sell, or Hold?
$0.50
-0.83 (-62.50%)
▼
5d:
-61.92%
30d:
-62.5%
90d:
-87.62%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Mar 12, 2026
Updated Mar 16, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (76%)
Quality Score
44/100
Position
FAIR
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$16.00
+3132.3% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$1.08 / $1.42
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: LYRA is down 61.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When LYRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LYRA is currently trading at $0.49, which is considered fair based on recent price action.
Technical Outlook: Technically, LYRA is in a strong downtrend. The price is currently testing key support at $1.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 62.5% recently.
Market Sentiment: LYRA scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.00 (+3132.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LYRA is in a strong downtrend. The price is currently testing key support at $1.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 62.5% recently.
Market Sentiment: LYRA scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.00 (+3132.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
44/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
76.3%
Trading Range & Key Levels
Support Level
$1.08
Resistance Level
$1.42
Current Trend
Strong Downtrend
Technical data as of
Mar 16, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-62.5%)
- BULLISH: Trading 3132.3% below Wall St target ($16.00)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.07
Wall Street Target
$16.00
(+3132.3%)
Revenue Growth (YoY)
-87.2%
Share LYRA Analysis
Share this live LYRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LYRA)
Bearish
4 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Mar 16, 2026
Daily AI digest
AI Retail Discussion Summary:
Negative sentiment prevails on $LYRA as delisting and appeal rejection messages circulate on StockTwits, with no positive news articles to offset the bearish tone.
Key Retail Themes:
Delisting
Appeal Rejection
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 17, 2026 2:40 PM ET
Data refreshes hourly during market hours. Next update: 3:40 PM
Data refreshes hourly during market hours. Next update: 3:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LYRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$469 | 35 SELL |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 34 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 38 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LYRA Research Pages
LYRA Technical Chart
LYRA Price Prediction
LYRA Intrinsic Value DCF
LYRA Earnings Date
LYRA Investment Advisor
LYRA Fair Price Analyzer
LYRA Target Price Playground
LYRA 5-Day Options Simulator
LYRA LEAP Simulator
LYRA Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
LYRA Competitors
Part B: Tradestie Flagship Market Scanners